MEETING OF NATIONAL MANAGERS OF TUBERCULOSIS CONTROL PROGRAMMES

1
MEETING OF NATIONAL MANAGERS OF TUBERCULOSIS
CONTROL PROGRAMMES

• EMRO, RABAT, MOROCCO,
• 17-19 JUNE 2003

2
COUNTRY EXPIERIANCE ON GLOBAL TB DRUG FACILITY
(GDF)

• Dr. Bashir A Suleiman
• National TB Focal Point
• WHO Somalia

3

• What is Global Drug Facility (GDF)
• The Global TB Drug Facility (GDF) is a mechanism
  to expand access to, and availability of,
  high-quality TB drugs to facilitate global DOTS
  expansion
• The GDF will enable governments and
  non-governmental organizations (NGOs) to
  implement effective TB control programmes based
  on the DOTS strategy
• By securing the timely supply of quality TB
  drugs, the GDF will complement other activities
  designed to improve coverage and quality of
  global TB control.

4
How it started ?

• In March 2000, Ministers of Health, Finance and
  Development Planning from twenty of the highest
  TB burden countries endorsed the "Amsterdam
  Declaration to Stop TB
• In May, the same year, the World Health Assembly
  encouraged all Member States to endorse the
  Amsterdam Declaration. In response, many
  countries have prepared or are preparing national
  plans of action to accelerate DOTS expansion

5

• Goals of the Global TB Drug Facility
• Ensure uninterrupted access to quality TB drugs
  for DOTS implementation. 
• Catalyze rapid DOTS expansion in order to achieve
  global TB targets.
• Stimulate political and popular support in
  countries worldwide for public funding of TB drug
  supplies.
• Secure sustainable global TB control and eventual
  elimination

6
Countries approved for GDF support
7

• WHO Somalia Approached GDF in late 2001 and
  applied for the Drugs available at GDF in which
  effectively it was approved
• The first supply of TB Drugs donated by GDF
  reached WHO Somalia on June 2002,
• GDF TB Drugs stock was consisting about 25 of
  the whole stock needed for about 7,000 TB
  patients expected to be registered in 2002 the
  rest 75 was secured by WHO budget line

8

• Early February 2003, Mickinsey group
• -independent external- evaluators, was sent to
  Somalia (and to other African countries) to
  evaluate the TB Drugs donated by Global Drug
  Facility to Somalia TB Program
• They met with senior WHO Medical officers
  Somalia, and National TB Focal Point. and
  discussed with them about evaluation check list
  consisting about

9

• Baseline (Rank of TB in National Health Policy,
  Budget of the program, mechanism of partnership,
  and HIV status in the country) in TB program in
  Somalia before GDF Support.
• TB Drug supply Management (Main procurement
  agencies, time between order and receiving
  clearing and delivering at central level,
  regimens used by TB program.) before GDF
• Application review, drug management, and feedback
  from GDF.

10

• After their initial meeting with WHO officers,
  they met with other partners who support Somalia
  TB program (consisting International agencies,
  and NGOs)
• SACB (Somali Aid Coordination Body)
• WFP ( World Food Program)
• EU (European Union)
• NGOs especially Norwegian Peoples Aid (NPA) and
  Medicine Sans Frontier Belgium (MSF-B)

11

• Next day the group visited the main warehouse of
  WHO Somalia, where TB drugs are also stored and
  supplied
• Finally the group were very appreciated and
  confirmed that their visit was well done as they
  firmly promised that they will send the feedback
  of their visit as soon as possible
• The feedback came in April 2003 with a positive
  manner and the approval of the 2nd Application
  for TB Program of Somalia

12
Case notification figure 95-02 (Somalia)
13
Table 2 Location, catchments population and
case detection rates of TB Centers
14
Table 4 Location, catchments population and
case detection rates of TB Centers
Total
3,711,372 6,013 1,739
30 27
15
Table 3 Location, catchments population and
case detection rates of TB Centers
16
Table 5 Location, catchments population and
case detection rates of TB Centers
17

• Unanimously it was agreed that Somalia TB program
  will move towards the 4 FDC, and gradual
  transition from loose drugs to 4 FDC (2003-2004)
  to blisters (2005-2006)

18
Table 1. Drug Requirement 2003-2004
19
Table 2. Costs for 2003-2004 drug procurement
20
.

• .

THANK YOU AND LETS TRY TO STOP TB
STOP TB